Drugs / Tofimilast
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00150397 | Mar → Nov 2005 | asthma | Pfizer | Completed | No outcome recorded |
| Phase 2 | NCT00219622 | May 2004 → Jul 2005 | chronic obstructive pulmonary disease | Pfizer | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | tofimilast | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00219622 ↗ |
| Known as | CP-325,366 | ChEMBL registry synonym — accepted as the source's own label CHEMBL217899 ↗ |
| Modality | Small molecule | — CHEMBL217899 ↗ |